IOL Chemicals and Pharmaceuticals Ltd

NSE: IOLCP · BSE: 524164 · Pharmaceuticals & Biotechnology · 12 announcements

Share price: ₹204.19
Market cap: ₹5,994 Cr
Revenue (annual): ₹2,319 Cr
Net profit (annual): ₹137.6 Cr
P/E (TTM): 35.6×Sector 50.4×
Promoter holding: 62.28%+4.80% QoQ
FII holding: 4.87%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 3 Capacity Expansion 2 Regulatory Approval 1 Other Announcement 1 Financial Results 1 Annual General Meeting 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

17 Sep 2026 17:03 IST BSE

Earnings Call

IOL Chemicals and Pharmaceuticals Earnings Call Transcript: Key Takeaways

IOL Chemicals announced three strategic initiatives involving INR 500 Cr investment: Ibuprofen capacity expansion (to 18,000 MTPA), a new CDMO formulations facility, and a dedicated specialty chemical tolling facility.

Call: Guides 20% growth

Open call summary → Read the filing ↗

13 Aug 2026 17:23 IST BSE

Earnings Call

IOL Chemicals and Pharmaceuticals Earnings Call Transcript: Key Takeaways

IOL delivers a strong Q1FY27 beat driven by a 67% revenue jump in non-ibuprofen APIs and improved operating leverage.

Call: Guides 20% growth

Open call summary → Read the filing ↗

12 Aug 2026 16:55 IST BSE

Earnings Call

IOL Chemicals and Pharmaceuticals Investor Presentation: Key Takeaways

IOLCP reported strong Q1 FY27 results with Revenue at ₹756.3 Cr (up 37.1% YoY) and PAT at ₹64.5 Cr (up 89.9% YoY). The company is strategically shifting towards high-value non-Ibuprofen APIs.

Open call summary → Read the filing ↗